Mycophenolate mofetil maintenance therapy in renal transplant patients: Long-term results of the TranCept STAY study

Uwe Heemann, Volker Kliem, Klemens Budde, Amir Hamza, Jan Steffen Jürgensen, Federico Juarez, Wolfgang Arns, Thomas Rath, Hermann Haller

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

Background: This prospective observational study documented long-term renal function in transplant recipients receiving mycophenolate mofetil (MMF). Methods: Kidney allograft recipients >6 months post-transplantation, with a glomerular filtration rate (GFR) >20 mL/min, receiving MMF from time of transplantation were enrolled and followed for four yr. Subgroups were identified based on time between transplantation and enrollment: Y < 1 (6 months-1 yr); Y1-2 (>1-2 yr); Y2-5 (>2-5 yr) and Y > 5 (>5 yr). Results: A total of 2040 patients were analyzed; 780, 410, 541 and 309 in subgroups Y < 1, Y1-2, Y2-5 and Y > 5. For all patients combined GFR decreased during the observational period by approximately 1 mL/min/yr (median GFR (mL/min) was 50.8, 50.5, 48.7, and 47.6 at one, two, three, and four yr). Survival estimates for decline in renal function (>20% GFR decline at one time point) were 78%, 66%, 57%, and 51% at one, two, three and four yr, with no significant differences between subgroups (p > 0.05). In adult patients, higher doses of MMF (≥1 g/d) were associated with better GFR outcomes (median GFR (mL/min) 48.1 vs. 39.9 at four yr post-enrollment; p = 0.0037). When comparing the effects of MMF combined with calcineurin inhibitors (CNIs), GFR was increased with lower doses of tacrolimus or cyclosporin. There were no major tolerability or acute rejection problems and graft survival was similar in all subgroups (graft survival estimates for all patients combined were 99%, 95%, 92%, and 90% at one, two, three, and four yr). Conclusions: Long-term MMF immunosuppression preserves renal function and higher MMF doses combined with lower CNI doses may provide better patient outcomes.

Original languageEnglish
Pages (from-to)919-926
Number of pages8
JournalClinical Transplantation
Volume26
Issue number6
DOIs
StatePublished - Nov 2012

Keywords

  • Glomerular filtration rate
  • Maintenance therapy
  • Mycophenolate mofetil
  • Nephrotoxicity

Fingerprint

Dive into the research topics of 'Mycophenolate mofetil maintenance therapy in renal transplant patients: Long-term results of the TranCept STAY study'. Together they form a unique fingerprint.

Cite this